Yam P, Petz L D, Ali S, Stock A D, Wallace R B
Department of Clinical and Experimental Immunology, City of Hope National Medical Center, Duarte, CA.
Am J Hum Genet. 1987 Nov;41(5):867-81.
Although numerous genetic markers are available for studying chimerism after bone marrow transplantation (BMT), there remains a need for a practical and highly informative method that is applicable in the early posttransplantation period. Using DNA restriction-fragment-length polymorphisms (RFLPs), we have evaluated the feasibility of developing a single synthetic oligonucleotide probe to study post-BMT chimerism. We have thus tested three candidate probes, termed O-3315-32, O-3315-80, and O-AY-29, that are homologous to tandemly repetitive sequences. Our results demonstrated donor-specific and recipient-specific fragments in 11 of 11 HLA-matched sibling pairs tested using probes O-3315-32 and O-3315-80. When probe O-AY-29 was used, 14 of 17 sibling pairs showed both donor and recipient markers, one had only a recipient marker, and two were identical. We showed that each of the three synthetic probes was effective in documenting donor marrow engraftment, mixed hematopoietic chimerism, the patient's pre-BMT phenotype (by using cultured skin fibroblasts obtained after BMT), and the origin of the malignant hematopoietic cells (i.e., of donor or recipient origin) in patients who developed recurrent hematologic malignancy following BMT. Compared with the use of cloned genomic probes, there are several important advantages to the use of synthetic oligonucleotide probes in studying post-BMT chimerism. Synthetic probes have absolute hybridization specificity and can be designed to suit the purposes of an individual study, since they have adjustable specificity that can be altered by changes in the length of the probe and by changes in the hybridization temperature. A single synthetic probe analogous to several highly polymorphic loci can have a polymorphism information content sufficiently high so that all but a small percentage of BMT patients could be followed easily; for example, if a probe were complementary to three highly polymorphic unlinked loci, it would discriminate approximately 98% of sibling donor/recipient pairs. This would be accomplished using only one restriction-endonuclease digestion and only one gel electrophoresis. Since other genetic markers, e.g., red blood cell antigens, immunoglobulin allotypes, and chromosome analysis, are not uniformly informative and, in some cases, cannot be used in the early posttransplantation period, the use of synthetic oligonucleotide probes for analysis of DNA RFLP is emerging as the method of choice for studies of post-BMT chimerism. This method will allow for the development of new knowledge that has not been possible with previous methods.
尽管有许多遗传标记可用于研究骨髓移植(BMT)后的嵌合现象,但仍需要一种实用且信息丰富的方法,适用于移植后的早期阶段。利用DNA限制性片段长度多态性(RFLP),我们评估了开发一种单一合成寡核苷酸探针来研究BMT后嵌合现象的可行性。我们测试了三种候选探针,分别称为O - 3315 - 32、O - 3315 - 80和O - AY - 29,它们与串联重复序列同源。我们的结果表明,在使用探针O - 3315 - 32和O - 3315 - 80测试的11对HLA匹配的同胞对中,有11对出现了供体特异性和受体特异性片段。当使用探针O - AY - 29时,17对同胞对中有14对同时显示了供体和受体标记,1对只有受体标记,2对完全相同。我们表明,这三种合成探针中的每一种都能有效地记录供体骨髓植入、混合造血嵌合现象、患者移植前的表型(通过使用移植后获得的培养皮肤成纤维细胞),以及BMT后发生复发性血液系统恶性肿瘤患者的恶性造血细胞来源(即供体或受体来源)。与使用克隆基因组探针相比,在研究BMT后嵌合现象时,使用合成寡核苷酸探针有几个重要优点。合成探针具有绝对的杂交特异性,可以根据个体研究的目的进行设计,因为它们具有可调节的特异性,可以通过改变探针长度和杂交温度来改变。一个类似于几个高度多态性位点的单一合成探针可以具有足够高的多态性信息含量,以便除了一小部分BMT患者外,几乎所有患者都能被轻松追踪;例如,如果一个探针与三个高度多态性的非连锁位点互补,则可以区分大约98%的同胞供体/受体对。这只需进行一次限制性内切酶消化和一次凝胶电泳即可完成。由于其他遗传标记,如红细胞抗原、免疫球蛋白同种异型和染色体分析,并非都具有一致的信息性,并且在某些情况下不能在移植后的早期阶段使用,因此使用合成寡核苷酸探针分析DNA RFLP正在成为研究BMT后嵌合现象的首选方法。这种方法将带来以前方法无法获得的新知识发展。